Exocrine Pancreatic Insufficiency Market Expected to Hit USD 3.75 Billion by 2029

1. Exocrine Pancreatic Insufficiency Market Expected to Hit USD 3.75 Billion by 2029 Exocrine pancreatic insufficiency market was valued at USD 2.27 billion in 2021 and is expected to reach USD 3.75 billion by 2029, registering a CAGR of 6.50% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. Exocrine pancreatic insufficiency is caused by pancreatitis, cystic fibrosis, and other pancreatic diseases (EPI). EPI patients lack the pancreatic (digestive) enzymes needed to break down foods and absorb nutrients. It has the potential to cause malnutrition. PERT (pancreatic enzyme replacement treatment) may be beneficial. In EPI, pancreatic replacement therapy is a well- established treatment option that helps to reduce malabsorption and malnutrition. Lipase is responsible for fat digestion, protease is responsible for protein digestion, and amylase is responsible for starch digestion in the body. The USFDA approved the following pancreatic enzyme products (PEPs) for EPI treatment in 2009: Zenpep and Creon, Viokace and Ultresa in 2012, Pancreaze in 2010, and Pertzye in 2012. Download Exclusive Sample Report @ https://www.databridgemarketresearch.com/request- a-sample/?dbmr=global-exocrine-pancreatic-insufficiency-market Market Analysis and Insights: Exocrine Pancreatic Insufficiency Market: Exocrine pancreatic insufficiency (EPI) is a condition caused by a lack of exocrine pancreatic enzymes, which causes maldigestion or inability to digest food. EPI has been linked to a variety of pancreatic disorders and syndromes, including cystic fibrosis, chronic pancreatitis, Shwachman–Diamond syndrome, and others. Pancreatic enzyme replacement therapy (PERT) is the first-line treatment in individuals with exocrine pancreatic insufficiency. Treatment for pancreatic exocrine insufficiency with PERT is both safe and effective. Pancrease, Pertzye, Creon, Zenpep and Viokace are some of the medications utilized in PERT. Patients with exocrine pancreatic insufficiency are unable to effectively digest proteins, lipids, and carbohydrates in their food, resulting in poor nutritional absorption. Exocrine Pancreatic Insufficiency Market Scope and Market Size The exocrine pancreatic insufficiency market is segmented on the basis of diagnosis, treatment, drugs, symptoms, end-users and distribution channel. The growth amongst these segments will

2. help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications. Diagnosis  Imaging Tests  CT scan  Abdominal ultrasound  Others  Secretin Pancreatic Function Test  Fecal Fat Test  Fecal Elastase Test (FE-1) Treatment  Nutritional Management  Pancreatic Enzyme Replacement Therapy (PERT)  Others Drugs  Creon  Zenpep  Pancreaze  Ultresa  Viokace  Others Symptoms  Abdominal Pain  Constipation  Diarrhea  Fatty stools  Weight Loss  Others End-Users  Hospitals

3.  Specialty Clinics  Homecare  Others Distribution Channel  Hospital Pharmacy  Retail Pharmacy  Online Pharmacy  Others Browse Full Report Along with Facts and Figures @ https://www.databridgemarketresearch.com/reports/global-exocrine-pancreatic-insufficiency- market Some Trending Reports of Healthcare Industry: Spinal Cord Tumor Market Focuses on Key Drivers and Opportunities by 2029 Deviated Septum Market Cost Structure Analysis, Growth and Forecast to 2029 Hematology Drugs Market to Reach USD 165631.48 Million by 2029 Biohazard Bags Market Growth by Regions, Trends and Forecast to 2029 Keratoacanthoma Market Likely to Reach the USD 4,175.38 Million by 2028 Dental Elevator and Luxator Market Outlook, Key Players and Forecast by 2028 About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate. Contact Us: US: +1 888 387 2818 UK: +44 208 089 1725 Hong Kong: +852 8192 7475 Email – corporatesales@databridgemarketresearch.com